MAUDE Adverse Event Report: IBSA FARMACEUTICI ITALIA SRL/IBSA PHARMA INC. GELSYN - 3 INJ 16.8/2 ML ; ACID, HYALURONIC, INTRAARTICULAR
-
|
|
|
New Search | Submit an Adverse Event Report |
|
-